Novocure Ltd. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
177,072.00
102,673.00
269,511.00
219,901.00
185,437.00
248,012
Total Accounts Receivable
-
-
7,323.00
14,035.00
34,497.00
47,194
Inventories
1,892.00
3,446.00
13,594.00
25,549.00
22,025.00
22,555
Other Current Assets
4,519.00
5,711.00
3,476.00
2,388.00
3,175.00
3,608
Total Current Assets
183,483.00
111,830.00
293,904.00
261,873.00
245,134.00
321,369
Net Property, Plant & Equipment
5,176.00
5,749.00
12,581.00
18,620.00
18,067.00
15,366
Other Assets
252.00
297.00
851.00
1,588.00
2,097.00
3,058
Total Assets
188,911.00
117,876.00
307,336.00
282,081.00
265,298.00
339,793
Accounts Payable
10,286.00
10,033.00
16,755.00
18,356.00
17,206.00
Income Tax Payable
-
-
2,850.00
3,142.00
9,110.00
Other Current Liabilities
5,312.00
7,636.00
9,022.00
15,384.00
23,886.00
Total Current Liabilities
15,598.00
17,669.00
28,627.00
36,882.00
50,202.00
Long-Term Debt
346.00
321.00
23,097.00
96,231.00
97,342.00
Provision for Risks & Charges
752.00
1,421.00
3,622.00
4,990.00
2,697.00
Other Liabilities
436.00
590.00
1,170.00
1,633.00
1,493.00
Total Liabilities
17,132.00
20,001.00
56,516.00
139,736.00
151,734.00
Common Equity (Total)
171,604.00
97,700.00
250,820.00
142,345.00
113,564.00
Total Shareholders' Equity
171,779.00
97,875.00
250,820.00
142,345.00
113,564.00
Total Equity
171,779.00
97,875.00
250,820.00
142,345.00
113,564.00
Liabilities & Shareholders' Equity
188,911.00
117,876.00
307,336.00
282,081.00
265,298.00
Preferred Stock (Carrying Value)
175.00
175.00
-
-
-

About Novocure

View Profile
Address
No. 4 The Forum
St. Helier Jersey JE2 4UF
United Kingdom
Employees -
Website http://www.novocure.com
Updated 07/08/2019
Novocure Ltd. operates as an oncology company. It enages in developing its propriety technoclogy, Tumor Treating Fields, which uses electric fields tuned to specific frequencies to disrupt cancer cell division, inhibiting tumor growth, and causing affected cancer cells to die. The company was founded by Yoram Palti in 2000 and is headquartered in St.